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Purpose: The aim of this study is to report on preliminary data regarding the prevalence of major eye diseases in Korea.
Methods: We obtained data from the Korea National Health and Nutrition Examination Survey, a nation-wide 
cross-sectional survey and examinations of the non-institutionalized civilian population in South Korea (n = 
14,606), conducted from July 2008 to December 2009. Field survey teams included an ophthalmologist, 
nurses, and interviewers, traveled with a mobile examination unit and performed interviews and ophthalmologic 
examinations.
Results: The prevalence of visual impairment, myopia, hyperopia and astigmatism in participants over 5 years of 
age was 0.4 ± 0.1%, 53.7 ± 0.6%, 10.7 ± 0.4%, and 58.0 ± 0.6%, respectively. The prevalence of strabismus and 
blepharoptosis in participants over 3 years of age was 1.5 ± 0.1% and 11.0 ± 0.8%, respectively. In participants 
over 40 years of age, the prevalence of cataract, pterygium, early and late age-related macular degeneration, dia-
betic retinopathy and glaucoma was 40.2 ± 1.3%, 8.9 ± 0.5%, 5.1 ± 0.3%, 0.5 ± 0.1%, 13.4 ± 1.5%, and 2.1 ± 
0.2%, respectively.
Conclusions: This is the first nation-wide epidemiologic study conducted in South Korea for assessment of the prev-
alence of eye diseases by both the Korean Ophthalmologic Society and the Korea Center for Disease Control 
and Prevention. This study will provide preliminary information for use in further investigation, prevention, and 
management of eye diseases in Korea.
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Epidemiological studies provide information on the pre-
vention, treatment, and minimization of the impact of dis-
eases on society. In the past two decades, a wide range of epi-
demiologic studies in ophthalmology have provided im-
portant information on the pattern of visual impairment and 
the major eye diseases that cause such vision loss [1]. 
Although several epidemiological studies of several age-re-
lated eye diseases (e.g., glaucoma, age-related macular de-
generation, and cataract) have been conducted in Korea 
[2-4], these studies were hospital-based or were conducted 
primarily in urban areas. Data on the prevalence of diseases 
based on the number of hospital visits or surveys conducted 
in limited areas are easy to obtain; however, substantial dif-
ferences may exist between such data and that obtained in 
large-scale population studies, which are more accurate and 
can represent entire populations. 
Large-scale population-based studies conducted over the 
past two decades in many countries, including the United 
States [5-14], Western Europe [15-17],
 Australia [18-21], 
Japan [22-26],
 Singapore [27-30], and China [31-35],
 have 
been used to guide public health policy and plan preventive 
strategies. However, these studies were conducted mostly 
with regard to major age-related eye diseases, such as cata-
ract, glaucoma, age-related macular degeneration, and dia-
betic retinopathy, which are major causes of vision loss. 
Nation-wide epidemiological studies of all age groups for the 
prevalence of common eye diseases have not been performed.
The Korea Center for Disease Control and Prevention 
(CDC) conducted a series of Korea National Health and 
Nutrition Examination Surveys (KNHANES) in 1998, 2001, 
2005 and 2007-2009 for examination of the general health 
and nutrition status of Koreans. As of the fourth KNHANES 
(2007-2009), an annual total of 4,600 households were se-
lected, and the participating household members were inter-
viewed regarding health and nutrition and underwent a basic 
health examination that included blood pressure measure-
ments, blood and urine collection, a pulmonary function test, 
and a dental examination. Since the Korean Ophthalmologic 
Society has participated in this survey since 2008, oph-
thalmologic interviews and examinations were also con-
ducted with the same participants.
The purpose of this study is to investigate the national 
prevalence of common eye diseases in South Korea based on 
the survey data obtained from the KNHANES and to analyze 
the prevalence of diseases according to age and gender. Data 
obtained from KNHANES may offer further insight into the 
etiology, ethnic differences, and public health impact of the 
most common eye diseases affecting Korean people living in 
Asia.
Materials and Methods
Study design and population
The KNHANES is an ongoing population-based, cross- 
sectional epidemiological survey conducted in South Korea. 
Annually, 4,000 households in 200 enumeration districts 
were selected by a panel to represent the civilian, non-in-
stitutionalized South Korean population using the stratified, 
multistage clustered sampling method based on the 2005 
National Census Data. In KNHANES, sample design and 
size are estimated so that annual survey results represent the 
whole population in Korea. Therefore, annual survey re-
sults can be used as statistics to represent the overall Korean 
population. All members of each selected household were 
asked to participate in the survey, and the rate of partic-
ipation in the past several cycles ranged from 79% to 84%. 
From July 2008, ophthalmologic interviews and examina-
tions have been conducted. All examination and health in-
terviews were conducted by trained teams in mobile cen-
ters, while nutrition surveys were performed in individual 
households. 
This survey is aimed to determine the prevalence of the 
following vision status and common eye diseases in a pop-
ulation-based sample of Koreans: visual impairment and 
blindness, refractive errors, strabismus, blepharoptosis, cata-
ract, pterygium, diabetic retinopathy, age-related macular de-
generation (AMD), and glaucoma. The ophthalmologic sur-
vey was designed to be conducted over 5 years from 2008 to 
2013. The present study includes interim data from a survey 
conducted from July 2008 to December 2009. 
Examination procedures
Examination procedures were stratified according to age 
group. Participants aged 3 to 4 years old only underwent test-
ing for strabismus and blepharoptosis. Autorefraction and 
visual acuity testing and testing for strabismus and blephar-
optosis were performed among the participants ranging in 
age from 5 to 18 years old. The participants over 19 years of 
age underwent full ocular examinations, including autore-
fraction and visual acuity testing, testing for strabismus and 
blepharoptosis, slit lamp examinations, measurement of in-
traocular pressure (IOP), and fundus photographs. IOP was 
measured with a Goldmann applanation tonometer. For par-
ticipants meeting the glaucoma suspicion criteria, frequency 
doubling perimetry (FDT) was carried out. Phamacological 
pupil dilatation was performed for participants who had a 
history of diabetes mellitus or random blood glucose level of 
200 mg/dL or higher and/or fundus photograph suspected di-KC Yoon, et al. Prevalence of Eye Disease in South Korea
423
Ophthalmologic 
interview
Correction of 
visual acuity
Auto-refraction
Testing for strabismus & ptosis For 3 years or older participants
For 5 years or older participants
Slit lamp examination
(cataract, pterygium, depth of anterior chamber)
IOP measurement
Fundus photograph
without pupil dilatation
① IOP ≥22 mmHg or
② Suspected glaucoma on 
fundus examination
① Participants with diabetes mellitus or 
random blood sugar ≥200 mg or
② Suspected DR on fundus examination or
③ Difficulty in checking the fundus 
photograph due to media opacity
Visual field examination Fundus photograph after pupil dilatation
Visual acuity ＜0.8
Visual acuity
For 19 years 
or older 
participants
Fig. 1. Ophthalmologic ex-
amination flowchart for Korea
National Health and Nutrition
Examination Surveys. IOP 
= intraocular pressure; DR 
= diabetic retinopathy.
abetic retinopathy and/or difficulty obtaining a fundus photo-
graph due to media opacity (Fig. 1). All procedures described 
above except for fundus photography were performed before 
pupil dilatation. 
Examination methods and definition of eye diseases 
1) Questionnaire
A detailed interviewer-administered questionnaire was ad-
ministered for collection of relevant sociodemographic and 
medical information. Collected data included marital status, 
education, occupation, current housing status, lifestyle fac-
tors (including cigarette smoking history), optical symptoms, 
systemic medical and surgical history, and family history of 
eye diseases.
2) Visual acuity
Uncorrected visual acuity and/or best-corrected distance 
visual acuity (BCVA) were measured at a distance of 4 m us-
ing an international standard vision chart based on the 
LogMAR Scale (Jin’s vision chart, Seoul, Korea) [36]. 
Visual impairment was defined as a BCVA of 0.32 or worse 
in the best eye. Blindness was defined as BCVA of 0.02 or 
worse in the right or left eye.
3) Autorefraction
An autorefractor-keratometer (KR8800; Topcon, Tokyo, 
Japan) was used for all measurement of refraction, which 
were converted to spherical equivalents calculated as the 
spherical value plus half of the astigmatic value. Myopia was 
defined as an spherical equivalents of worse than -0.75 diop-
ters (D). Hyperopia was defined as spherical equivalents of 
worse than +1.0 D. Astigmatism was defined as a cylindrical 
error worse than +0.75 D.
4) Strabismus
Testing for strabismus included the cover-uncover test, 
prism and alternate cover test, and/or Krimsky test. Strabismus 
was defined as a manifest or latent ocular deviation at dis-
tance or near fixation with or without spectacle correction, 
esodeviation of 10 or more prism diopters, exodeviation of 
15 or more prism diopters, or any vertical deviation.
5) Blepharoptosis
Blepharoptosis was defined as presentation of a marginal 
reflex distance (MRD1) of 2 mm or less. Measurement of 
MRD1 was performed as follows: Positioned at the physi-
cian’s eye level, participants were asked to look straight 
ahead and relax while focusing at a distance target. Shining 
the penlight into the participant’s eye, the distance from the 
corneal light reflex to the upper eyelid margin was measured 
in millimeters. 
6) Slit lamp examination
A structured slit-lamp examination (Haag-Streit model 
BQ-900; Haag-Streit AG, Koeniz, Switzerland) was per-
formed by study ophthalmologists. The slit lamp examina-
tion was performed for determination of diseases in the ante-
rior segment of the eye (e.g., pterygium and cataract) and 
measurement of the IOP and anterior chamber depth using 
the Van Herick method [37]. Cataract was defined as a nu-
clear, cortical, or posterior subcapsular cataract in at least one 
eye. Pseudophakic and aphakic eyes were included as oper-
ated cataracts for the purpose of statistical analysis. A ptery-
gium was defined as a radially oriented fibrovascular lesion 
crossing over the nasal or temporal limbus. Grading was 
based on the visibility of the underlying episcleral blood ves-
sels [38].Korean J Ophthalmol Vol.25, No.6, 2011
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7) Fundus photography
A digital nonmydriatic fundus camera (TRC-NW6S, 
Topcon) and a Nikon D-80 digital camera (Nikon, Tokyo, 
Japan) were used to obtain the digital fundus images. Digital 
images were captured from all participants 19 years of age 
and older under physiological mydriasis. For each partic-
ipant, one 45° nonmydriatic digital retinal image centered on 
the fovea (field 2) was taken per eye (2 images per person in 
total). Each image was graded twice (a preliminary grade and a 
detailed grade) using the grading protocol of the International 
Age-related Maculopathy Epidemiological Study Group 
[39]. Optic nerve configuration and any retinal pathologic 
findings were recorded. Patients were defined as having ear-
ly AMD if they met any one of the following criteria: (1) the 
presence of soft indistinct drusen or reticular drusen, or (2) 
the presence of hard or soft distinct drusen with pigmentary 
abnormalities (increased pigmentation or hypopigmentation 
of the retinal pigment epithelium) in the absence of signs of 
late AMD. Late AMD included the presence of signs of wet 
AMD or geographic atrophy. Wet AMD was defined as reti-
nal pigment epithelial detachment or serous detachment of 
the sensory retina, subretinal or sub-RPE hemorrhages, and 
subretinal fibrous scars. Geographic atrophy was defined as a 
circular discrete area (of 175 microns in diameter) of retinal 
depigmentation with visible choroidal vessels, in the absence 
of signs of wet AMD.
In participants who had a history of diabetes mellitus or 
random blood glucose level of 200 mg/dL or higher and/or 
suspicion of diabetic retinopathy in nonmydriatic fudndus 
photography, 7 standard photographs from the Early Treatment 
for Diabetic Retinopathy Study were obtained from each eye 
after pharmacological pupil dilatation [40,41]. Diabetic ret-
inopathy was defined as the presence of 1 or more retinal mi-
croaneurysms or retinal blot hemorrhages with or without 
more severe lesions (hard exudates, soft exudates, intraretinal 
microvascular abnormalities, venous bleeding, new retinal 
vessels, and fibroproliferations) [42,43]. The prevalence of 
diabetic retinopathy was estimated in persons with diabetes 
mellitus.
8) Visual field test
FDT (Humphrey Matrix; Carl Zeiss Meditec Inc., Dublin, 
CA, USA) testing with the screening program N-30-1 was 
performed if the participants had elevated IOP ≥22 mmHg or 
a glaucomatous optic disc. FDT testing was repeated once if 
deemed unreliable. Patients were defined as having primary 
open angle glaucoma (POAG) if they met any one of the fol-
lowing category I or category II diagnostic criteria [44]. 
9) Category I diagnosis
The presence of FDT testing results, fixation error and 
false positive error ≤1: (1) elevated IOP ≥22 mmHg or (2) 
glaucomatous optic disc (loss of neuroretinal rim with verti-
cal or horizontal cup-disc ratio ≥0.6 or presence of optic disc 
hemorrhage or presence of retinal nerve fiber layer defect or 
asymmetry of vertical cup-disc ratio ≥0.2), (3) the presence 
of an abnormal FDT testing result (at least one location of re-
duced sensitivity) and (4) the presence of an open angle 
(peripheral anterior chamber depth >1/4 corneal thickness)
10) Category II diagnosis
Absence of FDT testing results or fixation error or false 
positive error ≥2, (1) the presence of an open angle (peripheral 
anterior chamber depth >1/4 corneal thickness) and (2) loss of 
neuroretinal rim with vertical cup-disc ratio ≥0.9, (3) asym-
metry of vertical cup-disc ratio ≥0.3 or (4) the presence of 
retinal nerve fiber layer defect and violation of the ISNT rule. 
Normal tension glaucoma (NTG) was defined using the 
same criteria for POAG with IOP ≤21 mmHg. Primary angle 
closure glaucoma (PACG) was diagnosed when all of the fol-
lowing four criteria were met: (1) the presence of a narrow, 
occludable angle (peripheral anterior chamber depth <1/4 
corneal thickness), (2) elevated IOP ≥22 mmHg, (3) glaucom-
atous optic disc (loss of neuroretinal rim with vertical or hori-
zontal cup-disc ratio ≥0.6 or the presence of optic disc hemor-
rhage or retinal nerve fiber layer defect), and (4) the presence 
of an abnormal FDT testing result (at least one location of re-
duced sensitivity) and fixation error, false positive error ≤1.
Quality control and data analysis
A total of 308 surveys were conducted by four survey 
teams within a time span of 77 weeks. Each survey team in-
cluded one ophthalmologist, one otolaryngologist, one den-
tist, three nurses, two interviewers, and one coordinator. The 
team moved with a mobile examination unit to pre-assigned 
locations and performed surveys for three days. A total of 
199 ophthalmology residents or ophthalmologists from 66 
training hospitals participated in this project as ophthalmo-
logic examiners. 
The quality of the survey was verified by the Epidemiologic 
Survey Committee of the Korean Ophthalmologic Society. 
Training of participating residents was periodically performed 
by acting staff members of the National Epidemiologic 
Survey Committee of the Korean Ophthalmologic Society. 
Data were collected using a combination of paper and digital 
formats. Imaging data, including fundus photographs, were 
retrieved directly from the imaging equipment and stored in 
their respective computers. All variables of interest were en-
tered into a password-protected Microsoft Office Access da-
tabase by a data entry clerk. For all digital information, origi-
nal data were copied into external hard disks daily and writ-
ten onto DVDs for storage.
Statistical analyses were performed using SAS ver. 9.2 
(SAS Institute, Cary, NC, USA). All estimates were obtained 
using the sample weight adjusted for oversampling, non-
response and the Korean population in 2008 to 2009, and 
standard errors of estimates were estimated accounting for 
the complex design of the survey. Prevalence estimates for 
all outcomes were performed for the overall sample and then KC Yoon, et al. Prevalence of Eye Disease in South Korea
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Table 1. Number of participants according to age and 
gender
Age group (yr) Male Female Total
3-4    203    174       377
  5-18 1,608 1,458    3,066
19-29    692    869    1,561
30-39    905 1,254    2,159
40-49    954 1,265    2,219
50-59    804 1,062    1,866
60-69   784 1,023    1,807
≥70   630    921    1,551
Total 6,580 8,026 14,606
Table 2. Prevalence of visual impairment according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 13,702 0.4 (0.1) 6,171 0.3 (0.1) 7,531 0.5 (0.1)
 5-18 2,993 0.0 (-) 1,571 0.0 (-) 1,422 0.0 (-)
19-29 1,530 0.0 (-) 679 0.0 (-)    851 0.0 (0.1)
30-39 2,117 0.2 (0.1) 88 0.3 (0.2) 1,230 0.1 (0.1) 0.08
40-49 2,178 0.1 (0.1) 936 0.2 (0.1) 1,242 0.0 (-)
50-59 1,824 0.3 (0.2) 790 0.3 (0.2) 1,034 0.4 (0.2) 0.82
60-69 1,717 1.2 (0.3) 746 0.9 (0.3)    971 1.5 (0.4) 0.18
≥70 1,343 3.8 (0.7) 562 2.9 (0.8)    781 4.4 (0.9) 0.17
Visual impairment was defined as a best-corrected distance visual acuity of 0.32 or worse in the best eye.
No = number of participants; Prev = prevalence; SE = standard error.
in age- and gender-stratified groups. Chi-square tests were 
used for analysis of differences in prevalence between 
genders. Logistic regression was used for analysis of differ-
ences in prevalence among age groups. 
Results
During the period from July 2008 to December 2009, a to-
tal of 14,606 participants from 5,986 households were re-
cruited and underwent an eye examination. Ages of the study 
participants ranged from 3 to 95 years of age: 6,580 were 
men and 8,026 were women. Table 1 shows the age and gen-
der distributions of the study population. 
Visual impairment and blindness
The overall prevalence of visual impairment was 0.4 ± 
0.1% (0.3 ± 0.1% in males, 0.5 ± 0.1% in females) (Table 2), 
while that in participants over 40 years of age was 0.9 ± 0.1% 
(0.6 ± 0.1% in males, 1.1 ± 0.2% in females) and was higher 
in females than males (p = 0.04). The prevalence of visual 
impairment in participants over 70 years of age was 3.8 ± 
0.7% (2.9 ± 0.8% in males, 4.4 ± 0.9% in females) and 
showed a significant increase with age (p < 0.01). The preva-
lence of blindness in either eye of participants over 65 years 
of age was 0.2 ± 0.1% (0.3 ± 0.2% in males, 0.1 ± 0.1% in fe-
males), and there were no statistically significant differences 
in relation to gender (p > 0.05). 
Refractive errors
The overall prevalence of myopia was 53.7 ± 0.6% (54.3 ± 
0.8% in males, 53.1 ± 0.7% in females) (Table 3). The preva-
lence of myopia in the group of participants ranging in age 
from 12 to 18 was 78.8 ± 1.3% (77.9 ± 1.7% in males, 79.9 ± 
1.7% in females) and was highest among the age groups (p < 
0.01). The prevalence of myopia was higher in females than 
in males in the 19 to 29 and over 70 years age groups (p < 
0.05 for both). 
The overall prevalence of hyperopia was 10.7 ± 0.4% (9.4 
± 0.4% in males, 12.0 ± 0.5% in females) (Table 3). In the 
group of participants ranging in age from 5 to 11, the preva-
lence of hyperopia was 5.3 ± 0.6% and then decreased with 
age. From the group of participants ranging in age from 40 to 
49, the prevalence of hyperopia again increased with age. 
The prevalence of hyperopia in the group of participants 
ranging in age from 60 to 69 and in the age group over 70 
years was 43.8 ± 1.4% and 47.1 ± 1.5%, respectively. In all 
age groups, there was no statistically significant difference in 
relation to gender (p > 0.05). 
The overall prevalence of astigmatism was 58.0 ± 0.6% 
(57.6 ± 0.8% in males, 58.4 ± 0.7% in females) (Table 3), 
while that in the 70 years or older age group was 92.0 ± 0.8% 
(92.9 ± 1.2% in males, 91.5 ± 1.1% in females), illustrating a 
significant increase with age (p < 0.01). In the group of par-
ticipants ranging in age from 30 to 39, the prevalence of as-
tigmatism was higher in males than in females (p < 0.01).
Strabismus
The overall prevalence of strabismus was 1.5 ± 0.1% (1.5 
± 0.2% in males, 1.5 ± 0.2% in females) (Table 4). The preva-
lence of strabismus in participants over 40 years of age was 
1.4 ± 0.2% (1.5 ± 0.2% in males, 1.2 ± 0.2% in females). In 
the group of participants ranging in age from 3 to 5 years, the 
prevalence of strabismus was 1.8 ± 0.7% (0.5 ± 0.4% in Korean J Ophthalmol Vol.25, No.6, 2011
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Table 3. Prevalence of refractive errors according to age
Age group (yr)
Myopia Hyperopia Astigmatism
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 13,636 53.7 (0.6) 13,636 10.7 (0.4) 13,636 58.0 (0.6)
 5-11 1,560 50.0 (1.5) 1,560 5.3 (0.6) 1,560 38.7 (1.4)
12-18 1,429 78.8 (1.3) 1,429 2.5 (0.4) 1,429 61.6 (1.6)
19-29 1,529 75.3 (1.2) 1,529 1.9 (0.4) 1,529 53.9 (1.4)
30-39 2,091 67.4 (1.2) 2,091 1.1 (0.3) 2,091 49.5 (1.3)
40-49 2,147 51.1 (1.3) 2,147 3.1 (0.4) 2,147 51.8 (1.4)
50-59 1,786 29.3 (1.3) 1,786 16.5 (1.0) 1,786 63.0 (1.3)
60-69 1,702 18.2 (1.1) 1,702 43.8 (1.5) 1,702 79.4 (1.1)
≥70 1,392 28.4 (1.2) 1,392 47.1 (1.5) 1,392 92.0 (0.8)
Myopia was defined as spherical equivalents of worse than -0.75 diopter. Hyperopia was defined defined as spherical equivalents of worse 
than +1.0 diopter. Astigmatism was defined as a cylindrical error worse than +0.75 diopter.
No = number of participants; Prev = prevalence; SE = standard error.
Table 4. Prevalence of strabismus according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 14,464 1.5 (0.1) 6,517 1.5 (0.2) 7,947 1.5 (0.2) 0.93
3-5      583 1.8 (0.7)    314 0.5 (0.4)    269 3.4 (1.4) 0.01
  6-11   1,385 1.8 (0.3)    725 1.7 (0.4)    660 1.9 (0.6) 0.75
12-18   1,448 1.9 (0.4)    756 1.7 (0.6)    692 2.1 (0.5) 0.65
19-29   1,543 1.5 (0.4)    687 1.1 (0.4)    856 2.0 (0.6) 0.18
30-39   2,138 1.7 (0.3)    898 2.1 (0.5) 1,240 1.2 (0.3) 0.09
40-49   2,197 1.0 (0.2)    942 1.0 (0.3) 1,255 0.9 (0.3) 0.86
50-59   1,852 1.4 (0.3)    797 1.5 (0.4) 1,055 1.3 (0.4) 0.68
60-69   1,787 1.6 (0.3)    776 2.2 (0.5) 1,011 1.1 (0.4) 0.07
≥70   1,531 1.9 (0.5)    622 2.2 (0.7)    909 1.8 (0.6) 0.69
Strabismus was defined as a heterotropia at distance and/or near fixation with or without spectacle correction, esodeviation of 10 or more 
prism diopters, exodeviation of 15 or more prism diopters, or any vertical deviation.
No = number of participants; Prev = prevalence; SE = standard error.
Table 5. Prevalence of blepharoptosis according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 14,489 11.0 (0.8) 6,530 12.1 (0.9) 7,959 10.0 (0.8) <0.01
3-5     580   9.9 (1.6)    313 10.1 (2.1)    267   9.7 (2.3)     0.01
  6-11   1,387 11.1 (1.6)    726 13.4 (2.0)    661   8.6 (1.5) <0.01
12-18   1,451   9.1 (1.2)    757 12.5 (1.7)    694   5.4 (0.9) <0.01
19-29   1,546   5.0 (0.9)    687 7.6 (1.4)    859   2.2 (0.7) <0.01
30-39   2,141   4.1 (0.7)    899 5.6 (1.0) 1,242   2.5 (0.5) <0.01
40-49   2,203   6.7 (0.9)    946 8.9 (1.3) 1,257   4.5 (0.8) <0.01
50-59   1,853 15.0 (1.5)    798 16.5 (1.7) 1,055 13.5 (1.9)    0.16
60-69   1,791 22.5 (1.7)    778 20.9 (2.0) 1,013 24.0 (1.9)    0.16
≥70   1,537 35.2 (2.3)    626 33.2 (2.8)    911 36.4 (2.6)    0.26
Blepharoptosis was defined as a marginal reflex distance 1 of 2 mm or less.
No = number of participants; Prev = prevalence; SE = standard error.
males, 3.4 ± 1.4% in females), and it was higher in females 
than in males (p < 0.01). There were no significant differ-
ences in relation to age (p > 0.05). The overall prevalence of 
esodeviation, exodeviation and vertical deviation was 0.2 ± 
0.0%, 1.1 ± 0.1% and 0.3 ± 0.0%, respectively.
Blepharoptosis
The overall prevalence of blepharoptosis was 11.0 ± 0.8% 
(12.1 ± 0.9% in males, 10.0 ± 0.8% in females) (Table 5 and 
Fig. 2). The prevalence of blepharoptosis in participants over KC Yoon, et al. Prevalence of Eye Disease in South Korea
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Fig. 2. Prevalence of blepharoptosis ac-
cording to age and gender.
Table 6. Prevalence of cataract according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 11,037 24.1 (0.9) 4,718 21.9 (1.0) 6,319 26.2 (1.0) <0.01
19-29   1,542   1.1 (0.3)    685   0.9 (0.4)    857   1.3 (0.5)    0.49
30-39   2,137   2.5 (0.4)    898   2.8 (0.7) 1,239   2.2 (0.4)    0.34
40-49   2,198 10.3 (1.1)    943 10.6 (1.3) 1,255 10.0 (1.3)    0.66
50-59   1,850 33.8 (2.0)   797 35.1 (2.7) 1,053 32.5 (2.2)    0.31
60-69   1,785 69.4 (2.1)   774 67.4 (2.7) 1,011 71.2 (2.2)    0.12
≥70   1,525 93.7 (0.8)   621 90.9 (1.6)   904 95.4 (0.8) <0.01
Any cataract in at least one eye: pseudophakic and aphakic eyes were also included as cataract.
No = number of participants; Prev = prevalence; SE = standard error.
Fig. 3. Prevalence of cataract according 
to age and gender.
40 years of age was 16.2 ± 1.1%. From the age of 40, the 
prevalence of blepharoptosis was increased with age, and it 
was highest in the age group over 70 years (35.2 ± 2.3%, p < 
0.01). The prevalence of blepharoptosis was higher in males 
than in females in participants from 6 to 49 years of age (p < 
0.05). 
Cataract
The prevalence of cataract in participants over 19 years of 
age was 24.1 ± 0.9% (21.9 ± 1.0% in males, 26.2 ± 1.0% in 
females) (Table 6 and Fig. 3), that in participants over 40 
years of age was 40.2 ± 1.3% (37.5 ± 1.5% in males, 42.6 ± 
1.3% in females), and that in participants over 60 years of age 
was 80.5 ± 1.3% (76.9 ± 1.8% in males, 83.2 ± 1.3% in fe-
males). These results indicate that prevalence of cataract 
tended to increase with age (p < 0.01). The prevalence of cat-
aract in participants over 40 years of age was higher in fe-
males than in males (p < 0.01). 
Pterygium
The prevalence of pterygium in participants over 19 years 
of age was 5.4 ± 0.3% (6.1 ± 0.5% in males, 4.7 ± 0.3% in fe-
males) (Table 7 and Fig. 4). The prevalence of pterygium in 
participants over 40 years of age was 8.9 ± 0.5% (10.1 ± 
0.8% in males, 7.7 ± 0.5% in females), while that in partic-
ipants over 60 years of age was 16.0 ± 0.8% (17.7 ± 1.3% in Korean J Ophthalmol Vol.25, No.6, 2011
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Table 7. Prevalence of pterygium according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 11,014   5.4 (0.3) 4,716   6.1 (0.5) 6,298   4.7 (0.3) <0.01
19-29 1,543   0.1 (0.1)   685   0.1 (0.1)    858   0.0 (0.0) -
30-39 2,130   0.9 (0.2)   896   1.5 (0.4) 1,234   0.3 (0.1) <0.01
40-49 2,192   3.9 (0.6)   943   5.0 (0.9) 1,249   2.8 (0.6)    0.03
50-59 1,845   7.2 (0.9)   797   9.6 (1.5) 1,048   4.8 (0.7) <0.01
60-69 1,780 13.6 (1.0)   773 14.9 (1.6) 1,007 12.5 (1.4)    0.07
≥70 1,524 18.9 (1.3)   622 21.8 (2.2)    902 17.1 (1.5)    0.07
No = number of participants; Prev = prevalence; SE = standard error.
Fig. 4. Prevalence of pterygium accord-
ing to age and gender.
Table 8. Prevalence of age-related macular degeneration according to age and gender
Age 
group 
(yr)
Early AMD
p-value
Late AMD
p-value Total Male Female Total Male Female
No Prev
(%) SE No Prev
(%) SE No Prev
(%) SE No Prev
(%) SE No Prev
(%) SE No Prev
(%) SE
Total 6,453   5.1 (0.3) 2,737 5.2 (0.5) 3,716 5.0 (0.4) 0.76 6,453 0.5 (0.1) 2,737 0.6 (0.2) 3,716 0.4 (0.1) 0.19
40-49 2,071   1.6 (0.3)   885 1.9 (0.5) 1,186 1.2 (0.4) 0.23 2,071 0.3 (0.1)   885 0.5 (0.3) 1,186 0.0 (-) -
50-59 1,706   4.1 (0.5)   737 4.7 (0.9)    969 3.5 (0.6) 0.31 1,706 0.1 (0.1)   737 0.2 (0.2)    969 0.0 (-) 0.14
60-69 1,527   8.8 (0.9)   660 9.6 (1.4)    867 8.1 (1.1) 0.42 1,527 0.9 (0.3)   660 0.8 (0.3)    867 0.9 (0.5) 0.84
≥70 1,149 13.6 (1.2)   455 13.3 (1.8)    694 13.8 (1.5) 0.82 1,149 1.5 (0.4)   455 1.9 (0.7)    694 1.3 (0.4) 0.38
Patients were defined as having early AMD if they met any one of the following criteria: 1) the presence of soft indistinct drusen or reticular 
drusen or, 2) the presence of hard or soft distinct drusen with pigmentary abnormalities (increased pigmentation or hypopigmentation of the 
retinal pigment epithelium) in the absence of signs of late AMD.
AMD = age-relaged macular degeneration; No. = numberof participants; Prev = prevalence; SE = standard error.
Fig. 5. Prevalence of early and late 
age-related macular degeneration ac-
cording to age and gender.
males, 14.8 ± 1.1% in females). The prevalence of pterygium 
increased with age (p < 0.01). The prevalence of pterygium 
in participants over 40 years of age was higher in males than 
females (p < 0.01). KC Yoon, et al. Prevalence of Eye Disease in South Korea
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Table 9. Prevalence of diabetic retinopathy in persons with diabetes mellitus according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 746 13.4 (1.5) 352 12.0 (1.9) 394 15.1 (2.2) 0.27
19-29     8 - -     3 - -    5 - -
30-39   33 - -   14 - -   19 - -
40-49 100 12.4 (3.6)   59 12.9 (5.0)   41 11.5 (5.1) 0.85
50-59 160 10.2 (2.6)   83   7.6 (2.8)   77 14.6 (5.2) 0.21
60-69 269 18.0 (2.8) 127 20.8 (4.2) 142 15.2 (3.2) 0.26
≥70 176 12.3 (3.1)   66   7.5 (3.6) 110 14.6 (4.3) 0.23
Diabetic retinopathy was defined as the presence of 1 or more retinal microaneurysm or retinal blot hemorrhages with or without more severe 
lesions (hard exudates, soft exudates, intraretinal microvascular abnormalities, venous bleeding, retinal new vessels, and fibroproliferations).
No = number of participants; Prev = prevalence; SE = standard error.
Fig. 6. Prevalence of diabetic retinop-
athy in persons with diabetes mellitus ac-
cording to age and gender.
Age-related macular degeneration
The overall prevalence of early AMD over 40 years of age 
was 5.1 ± 0.3% (5.2 ± 0.5% in males, 5.0 ± 0.4% in females) 
(Table 8 and Fig. 5). The prevalence of early AMD in partic-
ipants over 60 years of age was 10.9 ± 0.7% (10.9 ± 1.2% in 
males, 10.8 ± 0.9% in females). The overall prevalence of 
late AMD over 40 years of age was 0.5 ± 0.1% (0.6 ± 0.2% in 
males, 0.4 ± 0.1% in females). The prevalence of late AMD 
in participants over 60 years of age was 1.1 ± 0.2% (1.2 ± 
0.3% in males, 1.1 ± 0.3% in females). The prevalence of 
AMD increased with age (p < 0.01). There were no statisti-
cally significant differences in relation to gender (p > 0.05). 
Diabetic retinopathy
The prevalence of diabetic retinopathy in participants over 
19 years of age was 13.4 ± 1.5% (12.0 ± 1.9% in males, 15.1 
± 2.2% in females) (Table 9 and Fig. 6). The prevalence of di-
abetic retinopathy in participants over 40 years of age was 
13.4 ± 1.5% (12.6 ± 2.0% in males, 14.3 ± 2.3% in females) 
(Table 9). The prevalence of diabetic retinopathy in partic-
ipants over 65 years of age was 13.1 ± 2.4% (11.0 ± 3.0% in 
males, 14.5 ± 3.4% in females). There were no statistically 
significant differences in the prevalence of diabetic retinop-
athy in relation to age or gender (p > 0.05).
Glaucoma
The prevalence of glaucoma in participants over 19 years 
of age was 1.4 ± 0.1% (1.6 ± 0.2% in males, 1.1 ± 0.2% in fe-
males) (Table 10 and Fig. 7) and was higher in males than in 
females (p < 0.05). The prevalence of glaucoma in partic-
ipants over 40 years of age was 2.1 ± 0.2% (2.5 ± 0.3% in 
males, 1.7 ± 0.2% in females). The prevalence of glaucoma 
in participants over 60 years of age was 3.3 ± 0.4% (3.7 ± 
0.6% in males, 3.0 ± 0.5% in females). In participants over 
40 years of age, the prevalence of POAG, PACG and NTG 
was 2.0 ± 0.2%, 0.1 ± 0.1% and 1.9 ± 0.2%, respectively. The 
prevalence of glaucoma increased with age (p < 0.01). The 
prevalence of glaucoma was higher in males than in females 
in participants aged 30 to 49 (p < 0.05). 
Discussion
In the past two decades, several epidemiologic studies have 
reported on the prevalence of common eye diseases in many 
countries [2-35,42,43,45-65]. Most of these population-based 
studies have been conducted in the United States among pre-
dominantly White, mixed White and African-American, or 
Hispanic populations [5-14]
 or in other countries, including 
Europe [15-17]
 and Australia [18-21]. There are a growing 
number of new population-based studies in Asia, including Korean J Ophthalmol Vol.25, No.6, 2011
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Table 10. Prevalence of glaucoma according to age and gender
Age group (yr)
Total Male Female
p-value
No Prev (%) SE No Prev (%) SE No Prev (%) SE
Total 10,035 1.4 (0.1) 4,284 1.6 (0.2) 5,751 1.1 (0.2) <0.05
19-29   1,457 0.3 (0.1)    646 0.1 (0.1)      811 0.5 (0.3)   0.22
30-39   2,017 0.7 (0.2)    848 1.0 (0.4) 1,169 0.2 (0.1) <0.01
40-49   2,095 1.0 (0.2)    898 1.4 (0.4) 1,197 0.5 (0.2) <0.05
50-59   1,720 2.3 (0.4)    737 2.8 (0.7)      983 1.9 (0.5)   0.20
60-69   1,585 2.2 (0.4)    682 2.5 (0.7)      903 1.9 (0.5)   0.41
≥70   1,161 4.9 (0.7)    473 5.7 (1.2)      688 4.4 (0.9)   0.40
No = number of participants; Prev = prevalence; SE = standard error.
Fig. 7. Prevalence of glaucoma accord-
ing to age and gender.
Japan [22-26,48,56], Singapore [27-30],
 China [31-35,46] 
and Taiwan [61,62]. However, even within a single Asian 
country, significant racial/ethnic variations may exist. The 
present study is the first investigating the prevalence of eye 
diseases in South Korea based on nationally representative 
data. 
The 10th Revision of the World Health Organization 
International Statistical Classification of Diseases, Injuries 
and Causes of Death defines visual impairment as a BCVA 
less than 20 / 60 but 20 / 400 or better in the best eye, and 
blindness is defined as a BCVA of worse than 20 / 400 in the 
best eye. The United States criteria define visual impairment 
as a BCVA of less than 20 / 40 but better than 20 / 200, and 
blindness as a BCVA of 20 / 200 or worse. Using the United 
States standard, the prevalence of visual impairment was 
0.97% to 2.34% in White Americans over 40 years of age 
[10]
 and 5.3% in African Americans over 65 years of age [8]. 
In a Japanese population of subjects over 40 years of age, the 
prevalence of visual impairment and blindness were 1.28% 
and 0.15%, respectively [25]. The prevalence of visual im-
pairment and blindness in China was reported as 1.1 % and 
0.3 %, respectively, in subjects over 40 years of age, accord-
ing to the World Health Organization definition [31]. In our 
study, when we defined visual impairment and blindness as a 
BCVA of 0.32 or worse and 0.01 or worse, respectively, the 
prevalence of visual impairment and blindness in the subjects 
over 40 years of age was 0.9% and 0.1%, respectively, sim-
ilar to the prevalence reported from China.
The prevalence of myopia has been reported as 25% in 
Western Europe [45], 26% in the United States [45],
 38% 
among Chinese individuals [46], and 41% to 43 % in Japan 
[47,48]. In the present study, the prevalence of myopia in 
adult Koreans over 40 years of age was 35.7%, which was 
higher than those of Western Europe and United States and 
similar to those reported in China and Japan. Changes in the 
prevalence and value of refractive errors do occur with age 
starting in childhood [49]. Many studies have reported a de-
crease of the prevalence of myopia and a simultaneous in-
crease in the prevalence of hyperopia with increasing age 
[50-52]. Results of our study were in agreement with those 
findings.
In this study, the overall prevalence of strabismus in the 3 
to 5 and 6 to 11 year age groups was 1.8% in South Korea. 
The prevalence of strabismus has been reported as 2.3% in 
subjects 2 to 5 years of age in the United Kingdom [53],
 3.1% 
in subjects 4 to 7 years of age in the United States [54], 2.7% 
in subjects under the age of 7 years in Sweden [55],
 and 1.3% 
in subjects 6 to 12 years of age in Japan [56].
 There is a sig-
nificant ethnic component influencing the distribution of 
strabismus: Studies in Asian populations have reported an 
esotropia to exotropia ratio of less than 1, while in European 
populations, the ratio was greater than 1 [53-56]. Our study 
demonstrated an esotropia to exotropia ratio of less than 1, 
similar to results from other Asian countries [56].
Blepharoptosis, drooping of the upper eyelid, is one of the 
most common upper eyelid diseases. Symptoms relate to im-KC Yoon, et al. Prevalence of Eye Disease in South Korea
431
pairment of the superior visual field and central vision in se-
vere cases. Even though blepharoptosis is generally known 
to exist below 4 to 5 mm of MRD1 in Western populations, 
there are no accurate definitions and available data on the 
prevalence of blepharoptosis, particularly among Asians. 
Except for Nigeria, the prevalence of blepharoptosis has not 
been reported. In the Nigeria study, blepharoptosis was de-
fined as the amount of the cornea covered by more than 2 mm 
by the upper eyelid, and the prevalence of blepharoptosis 
among school children under the age of 16 years was 1.2% 
[57]. There are no accurate diagnostic criteria about blephar-
optosis for Asian or Korean populations. However, depend-
ing on race, there are many differences in facial anatomy. 
Therefore, we defined blepharoptosis as less than 2 mm of 
MRD1 with consideration for anatomical differences of the 
eyelids and orbit. In our study, the prevalence of blephar-
optosis in the 3 to 5, 6 to 11 and 12 to 18 age groups were 
9.9%, 11.1% and 9.1%, respectively, higher than prevalences 
reported in Nigeria. One of the main objectives of this study 
is to estimate the prevalence of blepharoptosis in Koreans. In 
future studies, appropriate diagnostic criteria should be es-
tablished for use in Korean people.
The prevalence of cataract has been reported as 22.3% in 
the United States [29], 40.4% in Myanmar [55] and 35.0% in 
China [28]. In the present study, the prevalence of cataract in 
adult Korean over 40 years of age was 40.2%. The preva-
lence of cataract was similar to those reported in Myanmar 
and China, where no statistically significant differences in 
prevalence were observed in relation to gender. However, in 
the United States and Korea, females showed a significantly 
higher prevalence of cataract than males.
Several population-based studies have examined the prev-
alence of pterygium and have indicated a prevalence ranging 
from 1.2% in a White population in urban Australia [21]
 to 
33.0% in a Chinese population of subjects 50 years or older 
in Doumen County, Southern China [58]. In our study, the 
prevalence of pterygium in subjects over 40 years of age was 
8.9%. Differences in prevalence of pterygium were observed 
among these studies. However, dominance in male gender 
and old age associated with formation of pterygium were 
similar to those observed in other studies.
Large-scale population-based studies have been conducted 
over the past two decades in order to identify the prevalence 
and risk factors of AMD [2,6,12,15-19,26,32,60]. Studies 
have demonstrated variations in the prevalence and risk fac-
tors of AMD. In the Blue Mountains Eye Study, the preva-
lence of early AMD was 8.7%, and the prevalence of late 
AMD was 1.1% [19]. In the Beijing Eye Study, the preva-
lence of early AMD and late AMD was 5.1% and 0.3%, re-
spectively [32].
 In addition, the prevalence of early AMD 
and late AMD was 3.5% and 0.5% in the Funagata Study 
[26].
  In the present study, the prevalence of early AMD and 
late AMD was 5.1% and 0.5%, respectively. Our study 
showed a low prevalence of AMD compared to those in 
White populations. In addition, the prevalence of AMD in 
our study was similar to those of Chinese and Japanese 
populations.
The prevalence of diabetic retinopathy in the United States 
was reported as 28.5% to 40.3% [13,14]. There are many 
population-based data on the prevalence of diabetic retinop-
athy in Asia [61-63]. In Taiwan, 35% of 527 diabetic subjects 
over 40 years of age had diabetic retinopathy based on clinical 
examination [61].
 However, recent studies in India indicate a 
much lower prevalence of diabetic retinopathy [62,63]. In the 
present study, the prevalence of diabetic retinopathy 
(subjects over 40 years of age) was 13.4%, much lower than 
the prevalence reported in the United States or Taiwan. This 
relatively low prevalence of diabetic retinopathy may be due 
to a short duration of diabetes in our study population.
Glaucoma is believed to be the leading global cause of sur-
gically irremediable blindness [64]. In the Baltimore Eye 
Survey, the prevalence of POAG was approximately four 
times higher in black people (4% to 5%) than in white people 
(1.1%) [65]. In recent years, several studies have been con-
ducted on the epidemiology of glaucoma in Asian people 
[22-24,27,66]. The prevalence ranges of POAG and PACG 
have been reported as 1.6% to 3.9% and 0.4% to 1.0%, 
respectively.
 In this study, the prevalence of POAG and PACG 
was 2.0% and 0.1%. The prevalence of POAG was similar to 
those reported in other Asian countries [22-24,27,66].
 In con-
trast, the prevalence of PACG was lower than those reported 
in other Asian countries [22-24,27,66]. Results of this study 
might have been underestimated as only the Van Herick 
method was used in the diagnosis of PACG.
Accurate epidemiological information may contribute to 
the proper delivery of health care, preventive screenings, and 
rehabilitative services to individuals with eye diseases. This 
study provides standardized protocols for examination of oc-
ular diseases and improvement of ocular examination ca-
pacity through education and quality control. Databases con-
taining results from examination of eye diseases and results 
of quality control can be utilized in future clinical studies. In 
addition, methodology used in this survey can be utilized as a 
guideline for use in new population-based studies which will 
be performed in the nation.
In summary, our nation-wide study demonstrated the prev-
alence of major eye diseases and potential ocular dis-
ease-vulnerable groups in Korea. To the best of our knowl-
edge, this is the first nation-wide epidemiologic study con-
ducted by both the Ophthalmologic Society and the CDC and 
is a powerful tool for use in investigation of the national 
prevalence of disease conditions. Further studies are needed 
using on-going surveys in order to better understand the etio-
logic or risk factors that may be associated with ophthalmo-
logic diseases and to evaluate proper interventions aimed at 
prevention of disease-related disabilities.
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